101 related articles for article (PubMed ID: 3082771)
1. Lysis of autologous tumor cells by high-density lymphocytes is potentiated by the streptococcal preparation OK432 (Picibanil).
Vánky F; Uchida A; Klein E; Willems J
Int J Cancer; 1986 Apr; 37(4):531-6. PubMed ID: 3082771
[TBL] [Abstract][Full Text] [Related]
2. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
Uchida A
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
Uchida A; Micksche M; Hoshino T
Cancer Immunol Immunother; 1984; 18(1):5-12. PubMed ID: 6333269
[TBL] [Abstract][Full Text] [Related]
5. Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.
Colotta F; Rambaldi A; Colombo N; Tabacchi L; Introna M; Mantovani A
Br J Cancer; 1983 Oct; 48(4):515-25. PubMed ID: 6626452
[TBL] [Abstract][Full Text] [Related]
6. Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.
Yanagawa E; Uchida A; Micksche M
Cancer Immunol Immunother; 1984; 17(1):1-6. PubMed ID: 6563940
[TBL] [Abstract][Full Text] [Related]
7. Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70.
Wei Y; Zhao X; Kariya Y; Fukata H; Teshigawara K; Uchida A
Cancer Res; 1996 Mar; 56(5):1104-10. PubMed ID: 8640768
[TBL] [Abstract][Full Text] [Related]
8. [Induction of activated natural killer cells by the streptococcal preparation OK432 (I). Induction from spleen cells of normal or tumor-bearing mouse primed in vivo and subsequently challenged in vitro with OK432].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1370-8. PubMed ID: 2809371
[TBL] [Abstract][Full Text] [Related]
9. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432.
Christmas SE; Meager A; Moore M
Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735
[TBL] [Abstract][Full Text] [Related]
10. Killing of tumor cells with pleiotropic drug resistance by OK432-activated effector cells.
Allavena P; Peccatori F; Maggioni D; Pirovano P; Mantovani A
Immunopharmacol Immunotoxicol; 1989; 11(2-3):257-68. PubMed ID: 2621319
[TBL] [Abstract][Full Text] [Related]
11. Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: enhanced generation of soluble cytotoxic factors.
Uchida A; Klein E
Immunol Lett; 1985; 10(3-4):177-81. PubMed ID: 3899922
[TBL] [Abstract][Full Text] [Related]
12. [Identification and characterization of effector lymphocytes lysing autologous tumor cells].
Kumagai K; Fujii M; Abo T; Sawada H; Kato M; Itoh K; Satoh T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1462-8. PubMed ID: 2658829
[TBL] [Abstract][Full Text] [Related]
13. Cell regulatory and immunorestorative activity of picibanil (OK432).
Chirigos MA; Saito T; Talmadge JE; Budzynski W; Gruys E
Cancer Detect Prev Suppl; 1987; 1():317-28. PubMed ID: 3480058
[TBL] [Abstract][Full Text] [Related]
14. In vitro augmentation of natural killing activity by OK-432.
Uchida A; Micksche M
Int J Immunopharmacol; 1981; 3(4):365-75. PubMed ID: 6174467
[TBL] [Abstract][Full Text] [Related]
15. Auto-tumor immunity in patients with solid tumors: participation of CD3 complex and MHC class I antigens in the lytic interaction.
Vánky F; Roberts T; Klein E; Willems J
Immunol Lett; 1987 Oct; 16(1):21-6. PubMed ID: 3501402
[TBL] [Abstract][Full Text] [Related]
16. Biological response modifier as antigen: OK432-specific T-cell clone as an anti-tumor effector cell.
Ozaki S; Suginoshita T
Cell Immunol; 1989 May; 120(2):477-81. PubMed ID: 2785863
[TBL] [Abstract][Full Text] [Related]
17. OK-432 and IL-2-augmented cytotoxicity of human natural killer cells and cytotoxic T lymphocytes at the clonal level.
Gravekamp C; Vreugdenhil R; Bolhuis RL
FEMS Microbiol Immunol; 1988 Jan; 1(1):31-9. PubMed ID: 2978812
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.
Wakasugi H; Oshimi K; Miyata M; Morioka Y
J Clin Immunol; 1981 Jul; 1(3):154-62. PubMed ID: 6174541
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of tumoricidal activity of OK-432-specific L3T4+ Lyt2- T-cells.
Ozaki S; Suginoshita T; Watanabe T; Obayashi H
Cancer Res; 1990 Aug; 50(15):4630-4. PubMed ID: 2369739
[TBL] [Abstract][Full Text] [Related]
20. The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes.
Mizutani Y; Nio Y; Yoshida O
Cancer; 1992 Jun; 69(12):2999-3007. PubMed ID: 1591693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]